The invention relates to compounds of the general formula (I) where: R2 is a hydrogen or fluorine atom or a hydroxyl, cyano, trifluoromethyl, C1-6-alkyl, C1-6-alkoxy, or NR8R9 group; m and p have a value of 1; n and o have the same value which is 0 or 1; A is a covalent bond or a C1-8-alkylene group; R1 is an optionally substituted aryl or heteroaryl group; R3 is a hydrogen or fluorine atom or a C1-6-alkyl group or a trifluoromethyl group; R4 is an optionally substituted 5-membered heterocyclic compound; wherein the compounds can be in the state of a base or an acid addition salt. The present invention can be used in therapeutics.
本发明涉及一般式(I)的化合物,其中:R2是氢原子或
氟原子或羟基或
氰基或三
氟甲基或C1-6烷基或C1-6烷氧基或NR8R9基团;m和p的值为1;n和o的值相同,为0或1;A是共价键或C1-8烷基链;R1是可选择取代的芳基或杂环芳基基团;R3是氢原子或
氟原子或C1-6烷基或三
氟甲基基团;R4是可选择取代的5-成员
杂环化合物;其中,该化合物可以处于碱性或酸性盐的状态。本发明可用于治疗学中。